Pharm-Olam, LLC

Pharm-Olam is now Allucent. Purpose-built through the convergence of several leading providers including Pharm-Olam, Allucent is a global provider of comprehensive drug development solutions for small to mid-sized biotech companies across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise in early and late-stage development including consulting, clinical operations, biometrics, and clinical pharmacology.

LabConnect

LabConnect improves lives by partnering with pharma/biotech companies and clinical research organizations (CROs) to accelerate the development of new medicines around the world. An independent, global, one-stop-shop focused on delivering central laboratory services that are tailor-made, timely, and flexible. LabConnect provides unparalleled program oversight and support to meet the evolving study demands from traditional to increasingly complex trials. With deep and unmatched experience, LabConnect’s team of scientific experts serves as an extension of our client's clinical teams, quickly coordinating all laboratory-related needs and providing end-to-end analytical and logistical solutions. Offering a full suite of services from real-time sample tracking and data integration to groundbreaking scientific support services, LabConnect is the global partner of choice for central laboratory services. For more information, visit www.labconnect.com

George Clinical

George Clinical is a leading global clinical research organization founded in Asia-Pacific driven by scientific expertise and operational excellence. With over 20 years of experience and more than 500 people managing 40 geographical locations throughout the Asia-Pacific region, USA and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials. Stay up to date on the latest clinical research news, case studies and perspectives from George Clinical thought leaders by signing up for our monthly e-newsletter. georgeclinical.com/subscribe/newsletter

loxo@lilly

Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world. Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating oncology medicines that unequivocally show early signs of clinical activity and will matter to patients. Loxo@Lilly is a global organization with team members in Boulder, Colorado; Indianapolis, Indiana; New York City, New York; San Diego, California; South San Francisco, California; Stamford, Connecticut; and Madrid, Spain. When you engage with Loxo@Lilly on LinkedIn (and any other of Lilly's social media channels), you are agreeing to these Community Guidelines in addition to the Terms and Conditions or other legal notices provided by Lilly and those of LinkedIn: https://e.lilly/guidelines

advanced diabetes supply

Advanced Diabetes Supply provides diabetes testing supplies to people nationwide. Our highly trained staff and state of the art technology ensures fast and convenient home delivery anywhere in the country.